Inhibikase Therapeutics (IKT) Property, Plant & Equipment (Net) (2022 - 2025)
Inhibikase Therapeutics (IKT) Property, Plant & Equipment (Net) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 642,333.36 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 5.32 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.64 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.61 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5.27 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 31.48 Mn |
| 10 | Inhibikase Therapeutics | 407.51 Mn | 237.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 23,687.00 |
| Jun 30, 2025 | 23,687.00 |
| Mar 31, 2025 | 47,845.00 |
| Mar 31, 2025 | 47,845.00 |
| Dec 31, 2024 | 47,100.00 |
| Dec 31, 2024 | 47,100.00 |
| Sep 30, 2024 | 53,667.00 |
| Sep 30, 2024 | 53,667.00 |
| Jun 30, 2024 | 60,235.00 |
| Jun 30, 2024 | 60,235.00 |
| Mar 31, 2024 | 66,804.00 |
| Mar 31, 2024 | 66,804.00 |
| Dec 31, 2023 | 73,372.00 |
| Dec 31, 2023 | 73,372.00 |
| Sep 30, 2023 | 79,940.00 |
| Sep 30, 2023 | 79,940.00 |
| Jun 30, 2023 | 86,523.00 |
| Jun 30, 2023 | 86,523.00 |
| Mar 31, 2023 | 231,489.00 |
| Mar 31, 2023 | 231,489.00 |